B
COLL icon

Bailard’s Collegium Pharmaceutical COLL Stock Holding History

Bailard’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,600
Closed -$230K – 703
2023
Q1 		$230K Hold
9,600
– – 0.01% 596
2022
Q4 		$223K Buy
+9,600
New +$194K 0.01% 622
2019
Q4 		– Sell
-11,000
Closed -$126K – 551
2019
Q3 		$126K Hold
11,000
– – 0.01% 510
2019
Q2 		$145K Hold
11,000
– – 0.01% 520
2019
Q1 		$167K Buy
+11,000
New +$176K 0.01% 511

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Bailard's COLL Position: Q2 2023 in Review

Bailard sold out of Collegium Pharmaceutical (COLL) in Q2 2023, closing a stake of 9,600 shares — an estimated $230K sold.

Bailard first reported a position in COLL in Q1 2019 and held it in 5 quarters. The position peaked at $230K in Q1 2023. 178 funds tracked by Wall St. Rank hold COLL as of Q2 2023.

  • Bailard reported no remaining Collegium Pharmaceutical position as of Q2 2023 after selling out during the quarter.
  • Bailard sold 9,600 Collegium Pharmaceutical shares in Q2 2023, an estimated $230K.
  • Bailard first reported a position in Collegium Pharmaceutical in Q1 2019 and held it in 5 quarters.
  • Bailard's Collegium Pharmaceutical position peaked at $230K in Q1 2023.
  • 178 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2023.

Based on Bailard's 13F filing for Q2 2023, filed 20 Jul 2023.